EVENTIDE ASSET MANAGEMENT, LLC

Position in ZTS — Zoetis Inc.

CIK 1442891 Boston, MA

Position in ZTS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$833,144

+$9,275 QoQ

Shares Held

7,048

+7.6% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

EVENTIDE ASSET MANAGEMENT, LLC holds $107,290,135 across 5 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	COLL	Collegium Pharmaceutical, Inc	1,424,282	$47,101,005
2	ADCT	ADC Therapeutics SA	5,701,655	$21,381,206
3	AMLX	Amylyx Pharmaceuticals, Inc.	1,513,958	$21,044,016
4	UTHR	UNITED THERAPEUTICS Corp	28,552	$16,930,764
5	ZTS	Zoetis Inc. This page	7,048	$833,144

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$833,144	7,048	+7.6%	Shares	Sole	2026-05-15
2025-12-31	$823,869	6,548	+6.8%	Shares	Sole	2026-02-13
2025-09-30	$896,795	6,129	+20.6%	Shares	Sole	2025-11-14
2025-06-30	$792,849	5,084	+95.8%	Shares	Sole	2025-08-14
2025-03-31	$427,596	2,597	-17.6%	Shares	Sole	2025-05-15
2023-12-31	$622,307	3,153	+41.0%	Shares	Sole	2024-02-20
2023-09-30	$389,019	2,236	+11.0%	Shares	Sole	2023-11-14
2023-03-31	$335,376	2,015	-85.1%	Shares	Sole	2023-05-15
2022-12-31	$1,987,804	13,564	-55.9%	Shares	Sole	2023-02-13
2022-09-30	$4,559,472	30,747	+54.5%	Shares	Sole	2022-11-14
2021-09-30	$3,863,386	19,900	-39.3%	Shares	Sole	2021-11-15
2021-06-30	$6,112,608	32,800	+14.7%	Shares	Sole	2021-08-16
2021-03-31	$4,503,928	28,600	+28.8%	Shares	Sole	2021-05-14
2020-12-31	$3,674,100	22,200	+26.1%	Shares	Sole	2021-02-16
2020-09-30	$2,910,512	17,600	+23.9%	Shares	Sole	2020-11-13
2020-06-30	$1,945,968	14,200	0.0%	Shares	Sole	2020-08-14
2020-03-31	$1,671,198	14,200	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.